Welcome to LookChem.com Sign In|Join Free
  • or
4-((1R,2R,6S,7S)-1,7-dimethyl-3,5-dioxo-11-oxa-4,9-diaza-tricyclo[5.3.1.02,6]undec-4-yl)-2-trifluoromethyl-benzonitrile is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

934418-72-1

Post Buying Request

934418-72-1 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

934418-72-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 934418-72-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,3,4,4,1 and 8 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 934418-72:
(8*9)+(7*3)+(6*4)+(5*4)+(4*1)+(3*8)+(2*7)+(1*2)=181
181 % 10 = 1
So 934418-72-1 is a valid CAS Registry Number.

934418-72-1Upstream product

934418-72-1Downstream Products

934418-72-1Relevant academic research and scientific papers

Design and synthesis of 4-[3,5-dioxo-11-oxa-4,9-diazatricyclo[5.3.1.0 2,6]undec-4-yl]-2-trifluoromethyl-benzonitriles as androgen receptor antagonists

Xiao, Hai-Yun,Balog, Aaron,Attar, Ricardo M.,Fairfax, David,Fleming, Linda B.,Holst, Christian L.,Martin, Gregory S.,Rossiter, Lana M.,Chen, Jing,Cvjic, Mary-Ellen,Dell-John, Janet,Geng, Jieping,Gottardis, Marco M.,Han, Wen-Ching,Nation, Andrew,Obermeier, Mary,Rizzo, Cheryl A.,Schweizer, Liang,Spires Jr., Thomas,Shan, Weifang,Gavai, Ashvinikumar,Salvati, Mark E.,Vite, Gregory

scheme or table, p. 4491 - 4495 (2010/10/02)

A novel series of 4-[3,5-dioxo-11-oxa-4,9-diazatricyclo[5.3.1.0 2,6]undec-4-yl]-2-trifluoromethyl-benzonitriles has been synthesized. The ability of these compounds to act as antagonists of the androgen receptor was investigated and several wer

Tricycloundecane compounds useful as modulators of nuclear hormone receptor function

-

Page/Page column 24, (2008/06/13)

Tricycloundecanes compounds, methods of using such compounds in the treatment of nuclear hormone receptor-associated conditions such as cancer and immune disorders, and pharmaceutical compositions containing such compounds are disclosed.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 934418-72-1